Loading…
Loading…

| PPH | VanEck Pharmaceutical ETF | $111.17 | $965.9M |
| JVAL | JPMorgan U.S. Value Factor ETF | $58.69 | $835.0M |
| DBND | DoubleLine Opportunistic Core Bond ETF | $44.11 | $716.6M |
| FEPI | REX FANG & Innovation Equity Premium Income ETF | $42.69 | $704.4M |
| EBI | Longview Advantage ETF | $66.49 | $661.6M |
| FIIG | First Trust Intermediate Duration Investment Grade Corporate ETF | $20.08 | $649.5M |
| FLRT | Pacer Aristotle Pacific Floating Rate High Income ETF | $46.87 | $632.4M |
| RAA | SMI 3Fourteen REAL Asset Allocation ETF | $30.17 | $610.3M |
| TOTR | T. Rowe Price Total Return ETF | $39.01 | $574.6M |
| CXSE | WisdomTree China ex-State-Owned Enterprises Fund | $36.45 | $478.5M |